Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Acute Myeloid Leukemia
9%
Apo2L
9%
Apoptosis
9%
Apoptotic Cascade
18%
Bax Translocation
9%
Bcl-xL
9%
Bone Marrow Cells
9%
C-FLIP
9%
Caspase-3
9%
Caspase-7
9%
Caspase-8
9%
Caspase-8 Activation
9%
Caspase-9
9%
CD34+
9%
Conformational Change
27%
Cytochrome c (Cyt c)
9%
Death-inducing Signaling Complex
18%
Dominant-negative mutant
9%
Ectopic Expression
9%
Eukaryotic Translation Initiation Factor 4E (eIF4E)
9%
Hematopoietic Cells
9%
Human Leukemia Cells
100%
Induced Cell Death
9%
Jurkat
9%
K562
9%
Lethality
100%
Leukemia Cells
9%
Mitochondrial Apoptosis
9%
Mitochondrial Damage
18%
Multikinase Inhibitor
100%
Myeloid Cell leukemia-1 (Mcl-1)
100%
Pathway Activation
9%
Phosphorylation
9%
Procaspase-8
18%
Raji
9%
Receptor-mediated
9%
Smac
9%
Sorafenib
100%
Translational Mechanism
9%
Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)
9%
U266 Cells
9%
U937
9%
Biochemistry, Genetics and Molecular Biology
Bcl-xL
9%
Caspase 3
9%
Caspase 7
9%
Caspase 8
18%
Caspase-9
9%
CD34
9%
Cell Death
9%
Conformational Change
27%
Cytochrome C
9%
Death-Inducing Signaling Complex
18%
Downregulation
100%
Ectopic Expression
9%
FADD
9%
Hematopoietic Cell
9%
Primary Cell
9%
Programmed Cell Death
27%
Sorafenib
100%
TRAIL
100%
Tumor Necrosis Factor
9%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Myeloid Leukemia
9%
Caspase 3
9%
Caspase 7
9%
Caspase 8
18%
Caspase 9
9%
Cytochrome C
9%
Death Domain Receptor Signaling Adaptor Protein
18%
Initiation Factor 4E
9%
Lethality
100%
Leukemia
100%
Procaspase 8
18%
Receptor
18%
Sorafenib
100%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
9%